Latest filing published 07 Dec 2021 for Aptevo Therapeutics Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Fuad El-Hibri (board member) discloses dealings in 2 companies, chiefly Aptevo Therapeutics Inc. and Emergent BioSolutions Inc. The record holds 2 filings, all for trades on 3 December 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 7 December 2021, reports a transaction in Aptevo Therapeutics Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations